Systematic Evaluation of HLA-G 3’Untranslated Region Variants in Locally Advanced, Non-Metastatic Breast Cancer Patients: UTR-1, 2 or UTR-4 are Predictors for Therapy and Disease Outcome

Despite major improvements in diagnostics and therapy in early as well as in locally advanced breast cancer (LABC), metastatic relapse occurs in about 20% of patients, often explained by early micro-metastatic spread into bone marrow by disseminated tumor cells (DTC). Although neoadjuvant chemothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Rebmann, Vera, Schwich, Esther, Michita, Rafael Tomoya, Grüntkemeier, Lisa, Bittner, Ann-Kathrin, Rohn, Hana, Horn, Peter A., Hoffmann, Oliver, Kimmig, Rainer, Kasimir-Bauer, Sabine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790528/
https://www.ncbi.nlm.nih.gov/pubmed/35095919
http://dx.doi.org/10.3389/fimmu.2021.817132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790528/
https://www.ncbi.nlm.nih.gov/pubmed/35095919
http://dx.doi.org/10.3389/fimmu.2021.817132

Ejemplares similares